Opinion

Raffaele Colombo: TROPION-Breast01 results did not achieve statistical significance

Photo from Raffaele Colombo/X

Sep 25, 2024, 16:28

Raffaele Colombo: TROPION-Breast01 results did not achieve statistical significance

Raffaele Colombo shared on X:

“Datopotamab deruxtecan (Dato-DXd) in TROPION-Breast01 did not achieve statistical significance versus chemotherapy.”

Read further.
Source: Raffaele Colombo/X

cancer chemotherapy datopotamab deruxtecan OncoDaily Oncology TROPION-Breast01

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Aug 22, 2025, 13:01

EScoP Course on Lung and Thymic Pathology

Voices

Aug 22, 2025, 12:55

Triparna Sen: The SenLab at Ohio State Medical Oncology is Ready to Thaw Some Cells

Voices

Aug 22, 2025, 12:44

New Journal Neuro-Oncology Pediatrics Debuts from SNO and EANO

Voices

Aug 22, 2025, 12:33

Duke Welcomes New Radiation Oncology Resident Class - Duke Radiation Oncology

Insight

Aug 22, 2025, 12:31

Steven Wexner: Medical Therapies to Prevent Relapse of Crohn’s Disease After Surgery

Voices

Aug 22, 2025, 12:21

Patrick Hwu: Honored to Share Moffitt’s Mission with Florida Polytechnic University

Insight

Aug 22, 2025, 12:06

Francesco Maura: Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma

Voices

Aug 22, 2025, 12:05

Vaping is a Gateway with Broad Risks for Young People - LuCE

Voices

Aug 22, 2025, 12:02

Antonio Giordano Presents the Results of TRADE Trial

Voices

Aug 22, 2025, 11:59

Jad Chahoud Shares an Article About a New Phase 2 Trial on First-Line Treatment for Advanced NSCLC

Voices

Aug 22, 2025, 11:57

Ruben Mesa Highlights the Start of MPN Workshop of Carolinas

Insight

Aug 22, 2025, 11:54

Nieves Martinez Lago: KEYNOTE-585 Final Analysis